Trial intelligence / Profile preview

Effect of Oral Hygiene Regimen on Gingivitis

NCT07211061Phase 4Completed

Sponsor
Procter & Gamble
Start
Sep 2011
Primary completion
Nov 2011
Modality
DNA Intercalators/Alkylators, Conventional Liposomes
Countries
1
01

Overview

Phase 4, randomised trial of stannous fluoride and cetylpyridinium chloride in gingivitis (2 arms), sponsored by Procter & Gamble. Primary endpoint: Gingival Bleeding Index at 6 weeks. Started Sep 2011; status: completed.

02

Drugs

stannous fluoridecetylpyridinium chloride
03

Conditions

gingivitis

Beyond the preview

Go deeper on NCT07211061.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07211061.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call